Abstract Background and Objectives The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m

Objectives: to study the process of implementation of the increasing access to high-cost medicine listed in the Category E2 of the 2008 NLEM policy to practice under public health insurance systems: the Universal Health Coverage scheme (UC), Civil Servant Medical Benefit Scheme (CSMBS), and Social S

Abstract Cardiovascular disease risk assessment Pritaporn Kingkaew*, Tanunya Koopitakkajorn*, Patsri Srisuwan**, Sitaporn Youngkong*, Sripen Tantivess*, and Yot Teerawattananon* *Health Intervention and Technology Assessment Program, Ministry of Public Health, **Outpatient and Family Medicine

Abstract Disease prioritization for inclusion into Thailand’s population-based screening benefit package Sitaporn Youngkong*, Patsri Srisuwan†, Tanunya Koopitakkajorn*, Pritaporn Kingkaew*, Lily Ingsrisawang‡, Det Kedcham§, Sripen Tantivess*, Kanitta Bundhamcharoen#, Yot Teerawattananon* *He

Abstract Population-based screening for nephrosis, nephritis and renal stone in Thailand Patsri Srisuwan*, Tanunya Koopitakkajorn†, Det Kedcham‡, Pritaporn Kingkaew†, Sitaporn Youngkong†, Sripen Tantivess†, and Yot Teerawattananon† *Outpatient and Family Medicine Department, Phramongkutklao Ho

Abstract Population-based screening for atrial fibrillation (AF) in Thailand Patsri Srisuwan*, Tanunya Koopitakkajorn**, Pritaporn Kingkaew**, Sitaporn Youngkong**, Sripen Tantivess*, and Yot Teerawattananon* *Outpatient and Family Medicine Department, Phramongkutklao Hospital, **Health Interv

Abstract Effectiveness and cost-effectiveness of the population-based prostate cancer screening Tosanguan K*, Teerawattananon Y**Health Intervention and Technology Assessment Program Prostate cancer is a common malignancy in elderly men in western countries. It is the leading cause of mortality

Abstract Cost-utility of once-in-a-lifetime breast cancer screening with mammography in Thai women Thunyarat Anothaisintawee*,†, Narisa Tantai‡ and Yot Teerawattananon* *Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health †Department of Family Medicine,

Abstract Development of a population-based screening for anemia in Thailand Tanunya Koopitakkajorn*, Patsri Srisuwan†, Pritaporn Kingkaew*, Sitaporn Youngkong*, Napatcha Wongchaya‡, Supatcharin Suwannakerd‡, Sripen Tantivess*, and Yot Teerawattananon* *Health Intervention and Technology Assess

Abstract Cost-utility analysis of screening for hepatitis B viral infection in Thailand Narisa Tantai*, Pitsaphun Werayingyong**, Pattara Leelahavarong** and Yot Teerawattananon** *Pharmaceutical Department, Faculty of Medicine Siriraj Hospital, Mahidol University, **Health Intervention and Te